Sitagliptin/metforminklorid Genericon 50 mg/1000 mg filmom obložene tablete
| Name | Sitagliptin/metforminklorid Genericon 50 mg/1000 mg filmom obložene tablete |
|---|---|
| Marketing Authorisation Number | HR-H-024518604 |
| Active Substance | sitagliptinklorid hidrat metforminklorid |
| Composition | svaka tableta sadrži sitagliptinklorid hidrat u količini od 50 mg sitagliptina i 1000 mg metforminklorida |
| Pharmaceutical Form | Filmom obložena tableta |
| Manufacturer | PharOS MT Ltd, Birzebbugia, Malta Genericon Pharma Gesellschaft m.b.H., Graz, Austrija Rontis Hellas Medical and Pharmaceutical Products S.A., Larissa, Grčka |
| Marketing Authorisation Holder | Genericon Pharma Gesellschaft m.b.H., Hafnerstraße 211, Graz, Austrija |
| Marketing Authorisation Date | 17.02.2023 |
| MA Period of Validity | 17.02.2028 |
| Classification Number | UP/I-530-09/21-01/157 |
| Registration Number | 381-12-01/38-23-07 |
| Prescription | Medicinal product subject to medical prescription |
| Type of prescription | ponovljivi recept |
| Distribution | Supply through pharmacies (community) |
| Advertising to general public | not allowed |
| ATC Code | A10BD07 |
| Marketing status | stavljeno u promet |
| Shortage status | nema nestašice |
| SmPC | download |
| PL | download |
| Public Assessment Report | download |
| Summary of risk management plan | download |
